LYR-210 is a bioresorbable nasal implant specifically designed to deliver continuous anti-inflammatory medication for up to six months directly to the sinonasal passages. This innovative solution targets chronic rhinosinusitis patients who have not yet undergone sinus surgery, aiming to alleviate their symptoms effectively without requiring invasive interventions.